Ploth D W, Rudulph J, LaGrange R, Navar L G
J Clin Invest. 1979 Nov;64(5):1325-35. doi: 10.1172/JCI109589.
Experiments were done in normal rats to assess kidney, single nephron, and tubuloglomerular feedback responses during renin-angiotensin blockade with the converting enzyme inhibitor (CEI) SQ 20881 (E. R. Squibb & Sons, Princeton, N. Y.) (3 mg/kg, per h). Converting enzyme inhibition was documented by complete blockade of vascular responses to infusions of angiotensin I (600 ng/kg). Control plasma renin activity was 12.5+/-2.7 ng angiotensin I/ml per h (mean+/-SEM) and increased sevenfold with CEI (n = 7). There were parallel increases in glomerular filtration rate from 1.08+/-0.05 to 1.26+/-0.05 ml/min and renal blood flow from 6.7+/-0.4 to 7.5+/-0.5 ml/min. During CEI infusion absolute and fractional sodium excretion were increased 10-fold. Proximal tubule and peritubular capillary pressures were unchanged. Single nephron glomerular filtration rate (SNGFR) was measured from both proximal and distal tubule collections; SNGFR based only on distal collections was significantly increased by CEI. A significant difference was observed between SNGFR values measured from proximal and distal tubule sites (6.0+/-1.6 nl/min) and this difference remained unchanged after CEI administration. Slight decreases in fractional absorption were suggested at micropuncture sites beyond the late proximal tubule, whereas early distal tubule flow rate was augmented by CEI. Tubuloglomerular feedback activity was assessed by measuring changes in proximal tubule stop-flow pressure (SFP) or SNGFR in response to alterations in orthograde microperfusion rate from late proximal tubule sites. During control periods, SFP was decreased 11.2+/-0.4 mm Hg when the perfusion rate was increased to 40 nl/min; during infusion of CEI, the same increase in perfusion rate resulted in a SFP decrement of 6.7+/-0.5 mm Hg (P<.001). When late proximal tubule perfusion rate was increased from 0 to 30 nl/min, SNGFR was decreased by 15.0+/-1.2 nl/min during control conditions, and by 11.3+/-1.3 nl/min during CEI infusion. Attenuation of feedback responsiveness during CEI was also observed at lower perfusion rates with both techniques. These results indicate that blockade of the renin-angiotensin system with CEI reduces the activity of the tubuloglomerular feedback mechanism which may mediate the observed renal vasodilation.
在正常大鼠中进行了实验,以评估在用转化酶抑制剂(CEI)SQ 20881(E.R. Squibb & Sons公司,新泽西州普林斯顿)(3毫克/千克,每小时)阻断肾素 - 血管紧张素期间肾脏、单个肾单位和肾小管 - 肾小球反馈反应。通过完全阻断对血管紧张素I(600纳克/千克)输注的血管反应来证明转化酶受到抑制。对照血浆肾素活性为12.5±2.7纳克血管紧张素I/毫升每小时(平均值±标准误),使用CEI后增加了7倍(n = 7)。肾小球滤过率从1.08±0.05毫升/分钟平行增加到1.26±0.05毫升/分钟,肾血流量从6.7±0.4毫升/分钟增加到7.5±0.5毫升/分钟。在输注CEI期间,绝对和分数钠排泄增加了10倍。近端小管和肾小管周围毛细血管压力未改变。从近端和远端小管收集物中测量单个肾单位肾小球滤过率(SNGFR);仅基于远端收集物的SNGFR在使用CEI后显著增加。从近端和远端小管部位测量的SNGFR值之间观察到显著差异(6.0±1.6纳升/分钟),并且在给予CEI后这种差异保持不变。在近端小管晚期之后的微穿刺部位提示分数吸收略有下降,而早期远端小管流速在使用CEI后增加。通过测量近端小管停流压力(SFP)或SNGFR对来自近端小管晚期部位的顺行微灌注率变化的反应来评估肾小管 - 肾小球反馈活性。在对照期,当灌注率增加到40纳升/分钟时,SFP降低11.2±0.4毫米汞柱;在输注CEI期间,相同的灌注率增加导致SFP降低6.7±0.5毫米汞柱(P<0.001)。当近端小管晚期灌注率从0增加到30纳升/分钟时,在对照条件下SNGFR降低15.0±1.2纳升/分钟,在输注CEI期间降低11.3±1.3纳升/分钟。在两种技术的较低灌注率下也观察到CEI期间反馈反应性的减弱。这些结果表明,用CEI阻断肾素 - 血管紧张素系统会降低肾小管 - 肾小球反馈机制的活性,这可能介导了观察到的肾血管舒张。